{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:10:22Z","timestamp":1765667422016},"reference-count":79,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,14]]},"DOI":"10.7759\/cureus.31504","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:20:11Z","timestamp":1668471611000},"source":"Crossref","is-referenced-by-count":2,"title":["Preliminary Effects of Osteopathic Manipulative Medicine on Reactive Oxygen Species in Parkinson\u2019s Disease: A Randomized Controlled Pilot Study"],"prefix":"10.7759","author":[{"given":"James","family":"Docherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg R","family":"Leheste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayme","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Statistics. Parkinson\u2019s Foundation. (2020). Accessed. January 3, 2020: https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras C","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, et al.. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis. 2018, 4:21. 10.1038\/s41531-018-0058-0","journal-title":"NPJ Parkinsons Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.5.781","article-title":"Genetic and environmental risk factors for Parkinson's disease in a Chinese population","volume":"65","author":"Chan DK","year":"1998","unstructured":"Chan DK, Woo J, Ho SC, et al.. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry. 1998, 65:781-4. 10.1136\/jnnp.65.5.781","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000183359.50822.f2","article-title":"Progression of motor impairment and disability in Parkinson disease: a population-based study","volume":"65","author":"Alves G","year":"2005","unstructured":"Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology. 2005, 65:1436-41. 10.1212\/01.wnl.0000183359.50822.f2","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s2006","article-title":"Current approaches to the treatment of Parkinson's disease","volume":"4","author":"Jankovic J","year":"2008","unstructured":"Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat. 2008, 4:743-57. 10.2147\/ndt.s2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.6.721","article-title":"Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study","volume":"72","author":"Wood BH","year":"2002","unstructured":"Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002, 72:721-5. 10.1136\/jnnp.72.6.721","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/923493","article-title":"Should one measure balance or gait to best predict falls among people with Parkinson disease?","volume":"2012","author":"Duncan RP","year":"2012","unstructured":"Duncan RP, Earhart GM. Should one measure balance or gait to best predict falls among people with Parkinson disease?. Parkinsons Dis. 2012, 2012:923493. 10.1155\/2012\/923493","journal-title":"Parkinsons Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0319-5","article-title":"Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?","volume":"12","author":"Faden AI","year":"2015","unstructured":"Faden AI, Loane DJ. Chronic neurodegeneration after traumatic brain injury: Alzheimer disease, chronic traumatic encephalopathy, or persistent neuroinflammation?. Neurotherapeutics. 2015, 12:143-50. 10.1007\/s13311-014-0319-5","journal-title":"Neurotherapeutics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.1999.99.2.92","article-title":"Standard osteopathic manipulative treatment acutely improves gait performance in patients with Parkinson's disease","volume":"99","author":"Wells MR","year":"1999","unstructured":"Wells MR, Giantinoto S, D'Agate D, Areman RD, Fazzini EA, Dowling D, Bosak A. Standard osteopathic manipulative treatment acutely improves gait performance in patients with Parkinson's disease. J Am Osteopath Assoc. 1999, 99:92-8. 10.7556\/jaoa.1999.99.2.92","journal-title":"J Am Osteopath Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2011.111.6.382","article-title":"Effects of comprehensive osteopathic manipulative treatment on balance in elderly patients: a pilot study","volume":"111","author":"Lopez D","year":"2011","unstructured":"Lopez D, King HH, Knebl JA, Kosmopoulos V, Collins D, Patterson RM. Effects of comprehensive osteopathic manipulative treatment on balance in elderly patients: a pilot study. J Am Osteopath Assoc. 2011, 111:382-8. 10.7556\/jaoa.2011.111.6.382","journal-title":"J Am Osteopath Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2013.113.5.394","article-title":"Use of the SMART balance master to quantify the effects of osteopathic manipulative treatment in patients with dizziness","volume":"113","author":"Fraix M","year":"2013","unstructured":"Fraix M, Gordon A, Graham V, Hurwitz E, Seffinger MA. Use of the SMART balance master to quantify the effects of osteopathic manipulative treatment in patients with dizziness. J Am Osteopath Assoc. 2013, 113:394-403. 10.7556\/jaoa.2013.113.5.394","journal-title":"J Am Osteopath Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2021-0046","article-title":"Effect of osteopathic manipulation on gait asymmetry","volume":"122","author":"Hill CN","year":"2021","unstructured":"Hill CN, Romero M, Rogers M, Queen RM, Brolinson PG. Effect of osteopathic manipulation on gait asymmetry. J Osteopath Med. 2021, 122:85-94. 10.1515\/jom-2021-0046","journal-title":"J Osteopath Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2014.07.010","article-title":"Effectiveness of Anma massage therapy in alleviating physical symptoms in outpatients with Parkinson's disease: a before-after study","volume":"20","author":"Donoyama N","year":"2014","unstructured":"Donoyama N, Suoh S, Ohkoshi N. Effectiveness of Anma massage therapy in alleviating physical symptoms in outpatients with Parkinson's disease: a before-after study. Complement Ther Clin Pract. 2014, 20:251-61. 10.1016\/j.ctcp.2014.07.010","journal-title":"Complement Ther Clin Pract"},{"key":"ref14","article-title":"Gut microbiome changes with osteopathic treatment of constipation in Parkinson's disease: a pilot study","volume":"13","author":"Mancini JD","year":"2021","unstructured":"Mancini JD, Yao S, Martinez LR, Shakil H, Li TS. Gut microbiome changes with osteopathic treatment of constipation in Parkinson's disease: a pilot study. Neurology (ECronicon). 2021, 13:19-33.","journal-title":"Neurology (ECronicon)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/NRE-161400","article-title":"Osteopathic manipulation as\u00a0a\u00a0complementary approach to\u00a0Parkinson's\u00a0disease: a\u00a0controlled pilot\u00a0study","volume":"40","author":"DiFrancisco-Donoghue J","year":"2017","unstructured":"DiFrancisco-Donoghue J, Apoznanski T, de Vries K, Jung MK, Mancini J, Yao S. Osteopathic manipulation as\u00a0a\u00a0complementary approach to\u00a0Parkinson's\u00a0disease: a\u00a0controlled pilot\u00a0study. NeuroRehabilitation. 2017, 40:145-51. 10.3233\/NRE-161400","journal-title":"NeuroRehabilitation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2021-0203","article-title":"Effects of osteopathic manipulative treatment vs. osteopathic cranial manipulative medicine on Parkinsonian gait","volume":"122","author":"Terrell ZT","year":"2022","unstructured":"Terrell ZT, Moudy SC, Hensel KL, Patterson RM. Effects of osteopathic manipulative treatment vs. osteopathic cranial manipulative medicine on Parkinsonian gait. J Osteopath Med. 2022, 122:243-51. 10.1515\/jom-2021-0203","journal-title":"J Osteopath Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1515\/jom-2021-0081","article-title":"Efficacy of osteopathic manipulative treatment in patients with Parkinson's disease: a narrative review","volume":"121","author":"Li R","year":"2021","unstructured":"Li R, Jose A, Poon J, Zou C, Istafanos M, Yao SC. Efficacy of osteopathic manipulative treatment in patients with Parkinson's disease: a narrative review. J Osteopath Med. 2021, 121:891-8. 10.1515\/jom-2021-0081","journal-title":"J Osteopath Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa J","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson's disease. Front Neuroanat. 2015, 9:91. 10.3389\/fnana.2015.00091","journal-title":"Front Neuroanat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nature12808","article-title":"Transcranial amelioration of inflammation and cell death after brain injury","volume":"505","author":"Roth TL","year":"2014","unstructured":"Roth TL, Nayak D, Atanasijevic T, Koretsky AP, Latour LL, McGavern DB. Transcranial amelioration of inflammation and cell death after brain injury. Nature. 2014, 505:223-8. 10.1038\/nature12808","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner P","year":"2003","unstructured":"Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol. 2003, 53:S26-36. 10.1002\/ana.10483","journal-title":"Ann Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-6583-5_10","article-title":"DJ-1 as a biomarker of Parkinson\u2019s disease","author":"Saito Y","year":"2017","unstructured":"Saito Y. DJ-1 as a biomarker of Parkinson\u2019s disease. DJ-1\/PARK7 Protein: Parkinson\u2019s Disease, Cancer and Oxidative Stress-Induced Diseases. Ariga H, Iguchi-Ariga SM (ed): Springer, Singapore; 2017. 1037:149-71. 10.1007\/978-981-10-6583-5_10"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson's disease","volume":"16","author":"Dorszewska J","year":"2021","unstructured":"Dorszewska J, Kowalska M, Prendecki M, Piekut T, Koz\u0142owska J, Kozubski W. Oxidative stress factors in Parkinson's disease. Neural Regen Res. 2021, 16:1383-91. 10.4103\/1673-5374.300980","journal-title":"Neural Regen Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21191","article-title":"Oxidative damage in nucleic acids and Parkinson's disease","volume":"85","author":"Nakabeppu Y","year":"2007","unstructured":"Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K. Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res. 2007, 85:919-34. 10.1002\/jnr.21191","journal-title":"J Neurosci Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease","volume":"52","author":"Dexter DT","year":"1989","unstructured":"Dexter DT, Carter CJ, Wells FR, et al.. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem. 1989, 52:381-9. 10.1111\/j.1471-4159.1989.tb09133.x","journal-title":"J Neurochem"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study","volume":"9","author":"Dexter DT","year":"1994","unstructured":"Dexter DT, Holley AE, Flitter WD, et al.. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord. 1994, 9:92-7. 10.1002\/mds.870090115","journal-title":"Mov Disord"},{"key":"ref26","article-title":"Lipid peroxidation and tissue damage","volume":"13","author":"Mylonas C","year":"1999","unstructured":"Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo. 1999, 13:295-309.","journal-title":"In Vivo"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.49.34621","article-title":"Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease","volume":"274","author":"Pennathur S","year":"1999","unstructured":"Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J Biol Chem. 1999, 274:34621-8. 10.1074\/jbc.274.49.34621","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1713776","article-title":"3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases","volume":"130","author":"Bandookwala M","year":"2020","unstructured":"Bandookwala M, Sengupta P. 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases. Int J Neurosci. 2020, 130:1047-62. 10.1080\/00207454.2020.1713776","journal-title":"Int J Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000103641","article-title":"Peripheral blood markers of oxidative stress in Parkinson's disease","volume":"58","author":"Younes-Mhenni S","year":"2007","unstructured":"Younes-Mhenni S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G. Peripheral blood markers of oxidative stress in Parkinson's disease. Eur Neurol. 2007, 58:78-83. 10.1159\/000103641","journal-title":"Eur Neurol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm304","article-title":"Metabolomic profiling to develop blood biomarkers for Parkinson's disease","volume":"131","author":"Bogdanov M","year":"2008","unstructured":"Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, Bressman SS, Flint Beal M. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain. 2008, 131:389-96. 10.1093\/brain\/awm304","journal-title":"Brain"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease","volume":"33","author":"Chen CM","year":"2009","unstructured":"Chen CM, Liu JL, Wu YR, Chen YC, Cheng HS, Cheng ML, Chiu DT. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiol Dis. 2009, 33:429-35. 10.1016\/j.nbd.2008.11.011","journal-title":"Neurobiol Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/srep39171","article-title":"The involvement of dityrosine crosslinking in \u03b1-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease","volume":"6","author":"Al-Hilaly YK","year":"2016","unstructured":"Al-Hilaly YK, Biasetti L, Blakeman BJ, et al.. The involvement of dityrosine crosslinking in \u03b1-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease. Sci Rep. 2016, 6:39171. 10.1038\/srep39171","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.09.005","article-title":"Opposed effects of dityrosine formation in soluble and aggregated \u03b1-synuclein on fibril growth","volume":"429","author":"W\u00f6rdehoff MM","year":"2017","unstructured":"W\u00f6rdehoff MM, Shaykhalishahi H, Gro\u00df L, et al.. Opposed effects of dityrosine formation in soluble and aggregated \u03b1-synuclein on fibril growth. J Mol Biol. 2017, 429:3018-30. 10.1016\/j.jmb.2017.09.005","journal-title":"J Mol Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.54","article-title":"Transcriptional mutagenesis by 8-oxodG in \u03b1-synuclein aggregation and the pathogenesis of Parkinson's disease","volume":"47","author":"Basu S","year":"2015","unstructured":"Basu S, Je G, Kim YS. Transcriptional mutagenesis by 8-oxodG in \u03b1-synuclein aggregation and the pathogenesis of Parkinson's disease. Exp Mol Med. 2015, 47:e179. 10.1038\/emm.2015.54","journal-title":"Exp Mol Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(02)01259-4","article-title":"Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson\u2019s disease","volume":"336","author":"Abe T","year":"2003","unstructured":"Abe T, Isobe C, Murata T, Sato C, Tohgi H. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson\u2019s disease. Neurosci Lett. 2003, 336:105-8. 10.1016\/s0304-3940(02)01259-4","journal-title":"Neurosci Lett"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00089","article-title":"Increased oxidative stress markers in cerebrospinal fluid from healthy subjects with Parkinson's disease-associated LRRK2 gene mutations","volume":"9","author":"Loeffler DA","year":"2017","unstructured":"Loeffler DA, Klaver AC, Coffey MP, Aasly JO, LeWitt PA. Increased oxidative stress markers in cerebrospinal fluid from healthy subjects with Parkinson's disease-associated LRRK2 gene mutations. Front Aging Neurosci. 2017, 9:89. 10.3389\/fnagi.2017.00089","journal-title":"Front Aging Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1159\/000237221","article-title":"8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases","volume":"6","author":"Gmitterov\u00e1 K","year":"2009","unstructured":"Gmitterov\u00e1 K, Heinemann U, Gawinecka J, et al.. 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases. Neurodegener Dis. 2009, 6:263-9. 10.1159\/000237221","journal-title":"Neurodegener Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-191630","article-title":"What have we learned from cerebrospinal fluid studies about biomarkers for detecting LRRK2 Parkinson's disease patients and healthy subjects with Parkinson's-associated LRRK2 mutations?","volume":"9","author":"Loeffler DA","year":"2019","unstructured":"Loeffler DA, Aasly JO, LeWitt PA, Coffey MP. What have we learned from cerebrospinal fluid studies about biomarkers for detecting LRRK2 Parkinson's disease patients and healthy subjects with Parkinson's-associated LRRK2 mutations?. J Parkinsons Dis. 2019, 9:467-88. 10.3233\/JPD-191630","journal-title":"J Parkinsons Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2011_2260","article-title":"Altered oxidative stress levels in Indian Parkinson\u2019s disease patients with PARK2 mutations","volume":"58","author":"Vinish M","year":"2011","unstructured":"Vinish M, Anand A, Prabhakar S. Altered oxidative stress levels in Indian Parkinson\u2019s disease patients with PARK2 mutations. Acta Biochim Pol. 2011, 58:165-9. 10.18388\/abp.2011_2260","journal-title":"Acta Biochim Pol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2007.06.009","article-title":"Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population","volume":"14","author":"Sharma A","year":"2008","unstructured":"Sharma A, Kaur P, Kumar B, Prabhakar S, Gill KD. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population. Parkinsonism Relat Disord. 2008, 14:52-7. 10.1016\/j.parkreldis.2007.06.009","journal-title":"Parkinsonism Relat Disord"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00801-9","article-title":"Serum fractalkine and 3-nitrotyrosine levels correlate with disease severity in Parkinson's disease: a pilot study","volume":"37","author":"Gupta M","year":"2022","unstructured":"Gupta M, Paliwal VK, Babu GN. Serum fractalkine and 3-nitrotyrosine levels correlate with disease severity in Parkinson's disease: a pilot study. Metab Brain Dis. 2022, 37:209-17. 10.1007\/s11011-021-00801-9","journal-title":"Metab Brain Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217750088","article-title":"Biomarker definitions and their applications","volume":"243","author":"Califf RM","year":"2018","unstructured":"Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018, 243:213-21. 10.1177\/1535370217750088","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-021-03844-0","article-title":"Analysis of 19 urinary biomarkers of oxidative stress, nitrative stress, metabolic disorders, and inflammation using liquid chromatography-tandem mass spectrometry","volume":"414","author":"Martinez-Moral MP","year":"2022","unstructured":"Martinez-Moral MP, Kannan K. Analysis of 19 urinary biomarkers of oxidative stress, nitrative stress, metabolic disorders, and inflammation using liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2022, 414:2103-16. 10.1007\/s00216-021-03844-0","journal-title":"Anal Bioanal Chem"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.04.004","article-title":"Parkinson's disease and intensive exercise therapy--a systematic review and meta-analysis of randomized controlled trials","volume":"353","author":"Uhrbrand A","year":"2015","unstructured":"Uhrbrand A, Stenager E, Pedersen MS, Dalgas U. Parkinson's disease and intensive exercise therapy--a systematic review and meta-analysis of randomized controlled trials. J Neurol Sci. 2015, 353:9-19. 10.1016\/j.jns.2015.04.004","journal-title":"J Neurol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e31816f1550","article-title":"Effect of resistance training on blood oxidative stress in Parkinson disease","volume":"40","author":"Bloomer RJ","year":"2008","unstructured":"Bloomer RJ, Schilling BK, Karlage RE, Ledoux MS, Pfeiffer RF, Callegari J. Effect of resistance training on blood oxidative stress in Parkinson disease. Med Sci Sports Exerc. 2008, 40:1385-9. 10.1249\/MSS.0b013e31816f1550","journal-title":"Med Sci Sports Exerc"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: measurement using accurate biomarkers","volume":"48","author":"Seet RC","year":"2010","unstructured":"Seet RC, Lee CY, Lim EC, et al.. Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radic Biol Med. 2010, 48:560-6. 10.1016\/j.freeradbiomed.2009.11.026","journal-title":"Free Radic Biol Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2010.11.004","article-title":"Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease","volume":"17","author":"Hirayama M","year":"2011","unstructured":"Hirayama M, Nakamura T, Watanabe H, et al.. Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2011, 17:46-9. 10.1016\/j.parkreldis.2010.11.004","journal-title":"Parkinsonism Relat Disord"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2006.106.8.457","article-title":"Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment","volume":"106","author":"Licciardone JC","year":"2006","unstructured":"Licciardone JC, Russo DP. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment. J Am Osteopath Assoc. 2006, 106:457-63. 10.7556\/jaoa.2006.106.8.457","journal-title":"J Am Osteopath Assoc"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/1750-4732-1-3","article-title":"Patient expectations for placebo treatments commonly used in osteopathic manipulative treatment (OMT) clinical trials: a pilot study","volume":"1","author":"Fulda KG","year":"2007","unstructured":"Fulda KG, Slicho T, Stoll ST. Patient expectations for placebo treatments commonly used in osteopathic manipulative treatment (OMT) clinical trials: a pilot study. Osteopath Med Prim Care. 2007, 1:3. 10.1186\/1750-4732-1-3","journal-title":"Osteopath Med Prim Care"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S183170","article-title":"Osteopathic manipulation in the management of chronic pain: current perspectives","volume":"13","author":"Licciardone JC","year":"2020","unstructured":"Licciardone JC, Schultz MJ, Amen B. Osteopathic manipulation in the management of chronic pain: current perspectives. J Pain Res. 2020, 13:1839-47. 10.2147\/JPR.S183170","journal-title":"J Pain Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/life11080845","article-title":"Immediate effects of myofascial release on the thoracolumbar fascia and osteopathic treatment for acute low back pain on spine shape parameters: a randomized, placebo-controlled trial","volume":"11","author":"Brandl A","year":"2021","unstructured":"Brandl A, Egner C, Schleip R. Immediate effects of myofascial release on the thoracolumbar fascia and osteopathic treatment for acute low back pain on spine shape parameters: a randomized, placebo-controlled trial. Life (Basel). 2021, 11:10.3390\/life11080845","journal-title":"Life (Basel)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02516-5","article-title":"Toxic feedback loop involving iron, reactive oxygen species, \u03b1-synuclein and neuromelanin in Parkinson's disease and intervention with turmeric","volume":"58","author":"Jansen van Rensburg Z","year":"2021","unstructured":"Jansen van Rensburg Z, Abrahams S, Bardien S, Kenyon C. Toxic feedback loop involving iron, reactive oxygen species, \u03b1-synuclein and neuromelanin in Parkinson's disease and intervention with turmeric. Mol Neurobiol. 2021, 58:5920-36. 10.1007\/s12035-021-02516-5","journal-title":"Mol Neurobiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101508","article-title":"Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery","volume":"11","author":"Picca A","year":"2021","unstructured":"Picca A, Guerra F, Calvani R, Romano R, Coelho-J\u00fanior HJ, Bucci C, Marzetti E. Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson's disease: roads to biomarker discovery. Biomolecules. 2021, 11:10.3390\/biom11101508","journal-title":"Biomolecules"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Wei Z","year":"2018","unstructured":"Wei Z, Li X, Li X, Liu Q, Cheng Y. Oxidative stress in Parkinson's disease: a systematic review and meta-analysis. Front Mol Neurosci. 2018, 11:236. 10.3389\/fnmol.2018.00236","journal-title":"Front Mol Neurosci"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2018.11.005","article-title":"Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: a review of the causes and effects","volume":"662","author":"Hyatt H","year":"2019","unstructured":"Hyatt H, Deminice R, Yoshihara T, Powers SK. Mitochondrial dysfunction induces muscle atrophy during prolonged inactivity: a review of the causes and effects. Arch Biochem Biophys. 2019, 662:49-60. 10.1016\/j.abb.2018.11.005","journal-title":"Arch Biochem Biophys"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1080\/17461391.2011.654268","article-title":"Inactivity-induced oxidative stress: a central role in age-related sarcopenia?","volume":"14","author":"Derbr\u00e9 F","year":"2014","unstructured":"Derbr\u00e9 F, Gratas-Delamarche A, G\u00f3mez-Cabrera MC, Vi\u00f1a J. Inactivity-induced oxidative stress: a central role in age-related sarcopenia?. Eur J Sport Sci. 2014, 14:S98-108. 10.1080\/17461391.2011.654268","journal-title":"Eur J Sport Sci"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes AJ","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992, 55:181-4. 10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20150334","article-title":"Structural validity of the Mini-Balance Evaluation Systems Test (Mini-BESTest) in people with mild to moderate Parkinson disease","volume":"96","author":"Benka Wall\u00e9n M","year":"2016","unstructured":"Benka Wall\u00e9n M, Sorjonen K, L\u00f6fgren N, Franz\u00e9n E. Structural validity of the Mini-Balance Evaluation Systems Test (Mini-BESTest) in people with mild to moderate Parkinson disease. Phys Ther. 2016, 96:1799-806. 10.2522\/ptj.20150334","journal-title":"Phys Ther"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2522\/ptj.20160099","article-title":"Reliability and validity of force platform measures of balance impairment in individuals with Parkinson disease","volume":"96","author":"Harro CC","year":"2016","unstructured":"Harro CC, Marquis A, Piper N, Burdis C. Reliability and validity of force platform measures of balance impairment in individuals with Parkinson disease. Phys Ther. 2016, 96:1955-64. 10.2522\/ptj.20160099","journal-title":"Phys Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.05.034","article-title":"Validation of a UPDRS-\/MDS-UPDRS-based definition of functional dependency for Parkinson's disease","volume":"76","author":"Ramsay N","year":"2020","unstructured":"Ramsay N, Macleod AD, Alves G, et al.. Validation of a UPDRS-\/MDS-UPDRS-based definition of functional dependency for Parkinson's disease. Parkinsonism Relat Disord. 2020, 76:49-53. 10.1016\/j.parkreldis.2020.05.034","journal-title":"Parkinsonism Relat Disord"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable","volume":"25","author":"Whitehead AL","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016, 25:1057-73. 10.1177\/0962280215588241","journal-title":"Stat Methods Med Res"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2012.112.9.596","article-title":"Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain: results from the OSTEOPATHIC Trial","volume":"112","author":"Licciardone JC","year":"2012","unstructured":"Licciardone JC, Kearns CM, Hodge LM, Bergamini MV. Associations of cytokine concentrations with key osteopathic lesions and clinical outcomes in patients with nonspecific chronic low back pain: results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2012, 112:596-605. 10.7556\/jaoa.2012.112.9.596","journal-title":"J Am Osteopath Assoc"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2010.110.6.324","article-title":"Effects of rib raising on the autonomic nervous system: a pilot study using noninvasive biomarkers","volume":"110","author":"Henderson AT","year":"2010","unstructured":"Henderson AT, Fisher JF, Blair J, Shea C, Li TS, Bridges KG. Effects of rib raising on the autonomic nervous system: a pilot study using noninvasive biomarkers. J Am Osteopath Assoc. 2010, 110:324-30. 10.7556\/jaoa.2010.110.6.324","journal-title":"J Am Osteopath Assoc"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2017.110","article-title":"Single osteopathic manipulative therapy session dampens acute autonomic and neuroendocrine responses to mental stress in healthy male participants","volume":"117","author":"Fornari M","year":"2017","unstructured":"Fornari M, Carnevali L, Sgoifo A. Single osteopathic manipulative therapy session dampens acute autonomic and neuroendocrine responses to mental stress in healthy male participants. J Am Osteopath Assoc. 2017, 117:559-67. 10.7556\/jaoa.2017.110","journal-title":"J Am Osteopath Assoc"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2007.107.9.387","article-title":"Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study","volume":"107","author":"Degenhardt BF","year":"2007","unstructured":"Degenhardt BF, Darmani NA, Johnson JC, et al.. Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J Am Osteopath Assoc. 2007, 107:387-400. 10.7556\/jaoa.2007.107.9.387","journal-title":"J Am Osteopath Assoc"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14670","article-title":"Skeletal muscle aging: influence of oxidative stress and physical exercise","volume":"8","author":"Gomes MJ","year":"2017","unstructured":"Gomes MJ, Martinez PF, Pagan LU, et al.. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget. 2017, 8:20428-40. 10.18632\/oncotarget.14670","journal-title":"Oncotarget"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1080\/13547500701775563","article-title":"Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle","volume":"13","author":"Browne RW","year":"2008","unstructured":"Browne RW, Bloom MS, Schisterman EF, et al.. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers. 2008, 13:160-83. 10.1080\/13547500701775563","journal-title":"Biomarkers"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0316-2","article-title":"Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome","volume":"113","author":"Jordan W","year":"2006","unstructured":"Jordan W, Cohrs S, Degner D, et al.. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (Vienna). 2006, 113:239-54. 10.1007\/s00702-005-0316-2","journal-title":"J Neural Transm (Vienna)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101397","article-title":"Effects of diets high in animal or plant protein on oxidative stress in individuals with type 2 diabetes: a randomized clinical trial","volume":"29","author":"Pivovarova-Ramich O","year":"2020","unstructured":"Pivovarova-Ramich O, Markova M, Weber D, et al.. Effects of diets high in animal or plant protein on oxidative stress in individuals with type 2 diabetes: a randomized clinical trial. Redox Biol. 2020, 29:101397. 10.1016\/j.redox.2019.101397","journal-title":"Redox Biol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2013.12.015","article-title":"[Effect of a hypocaloric diet in the oxidative stress in obese subjects without prescription of exercise and antioxidants]","volume":"145","author":"Guti\u00e9rrez L","year":"2015","unstructured":"Guti\u00e9rrez L, Garc\u00eda JR, Rinc\u00f3n Mde J, Ceballos GM, Olivares IM. [Effect of a hypocaloric diet in the oxidative stress in obese subjects without prescription of exercise and antioxidants]. Med Clin (Barc). 2015, 145:1-6. 10.1016\/j.medcli.2013.12.015","journal-title":"Med Clin (Barc)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-16-15","article-title":"Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters","volume":"16","author":"Kuo DC","year":"2009","unstructured":"Kuo DC, Hsu SP, Chien CT. Partially hydrolyzed guar gum supplement reduces high-fat diet increased blood lipids and oxidative stress and ameliorates FeCl3-induced acute arterial injury in hamsters. J Biomed Sci. 2009, 16:15. 10.1186\/1423-0127-16-15","journal-title":"J Biomed Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2018.12.009","article-title":"How stable is oxidative stress level? An observational study of intra- and inter-individual variability in urinary oxidative stress biomarkers of DNA, proteins, and lipids in healthy individuals","volume":"123","author":"Martinez-Moral MP","year":"2019","unstructured":"Martinez-Moral MP, Kannan K. How stable is oxidative stress level? An observational study of intra- and inter-individual variability in urinary oxidative stress biomarkers of DNA, proteins, and lipids in healthy individuals. Environ Int. 2019, 123:382-9. 10.1016\/j.envint.2018.12.009","journal-title":"Environ Int"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3758-y","article-title":"Impact of exercise intensity on oxidative stress and selected metabolic markers in young adults in Ghana","volume":"11","author":"Diaba-Nuhoho P","year":"2018","unstructured":"Diaba-Nuhoho P, Ofori EK, Asare-Anane H, Oppong SY, Boamah I, Blackhurst D. Impact of exercise intensity on oxidative stress and selected metabolic markers in young adults in Ghana. BMC Res Notes. 2018, 11:634. 10.1186\/s13104-018-3758-y","journal-title":"BMC Res Notes"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8601028","article-title":"Combination of diet quality score, plasma carotenoids, and lipid peroxidation to monitor oxidative stress","volume":"2018","author":"Kim Y","year":"2018","unstructured":"Kim Y, Kim YJ, Lim Y, Oh B, Kim JY, Bouwman J, Kwon O. Combination of diet quality score, plasma carotenoids, and lipid peroxidation to monitor oxidative stress. Oxid Med Cell Longev. 2018, 2018:8601028. 10.1155\/2018\/8601028","journal-title":"Oxid Med Cell Longev"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang AE","year":"1998","unstructured":"Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med. 1998, 339:1044-53. 10.1056\/NEJM199810083391506","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson's disease: advances and strategies","volume":"22 Suppl 1","author":"Delenclos M","year":"2016","unstructured":"Delenclos M, Jones DR, McLean PJ, Uitti RJ. Biomarkers in Parkinson's disease: advances and strategies. Parkinsonism Relat Disord. 2016, 22 Suppl 1:S106-10. 10.1016\/j.parkreldis.2015.09.048","journal-title":"Parkinsonism Relat Disord"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070597","article-title":"The role of oxidative stress in Parkinson's disease","volume":"9","author":"Chang KH","year":"2020","unstructured":"Chang KH, Chen CM. The role of oxidative stress in Parkinson's disease. Antioxidants (Basel). 2020, 9:10.3390\/antiox9070597","journal-title":"Antioxidants (Basel)"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson's disease: how good are they?","volume":"36","author":"Li T","year":"2020","unstructured":"Li T, Le W. Biomarkers for Parkinson's disease: how good are they?. Neurosci Bull. 2020, 36:183-94. 10.1007\/s12264-019-00433-1","journal-title":"Neurosci Bull"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01932-x","article-title":"Artificial intelligence-enabled detection and assessment of Parkinson's disease using nocturnal breathing signals","volume":"28","author":"Yang Y","year":"2022","unstructured":"Yang Y, Yuan Y, Zhang G, et al.. Artificial intelligence-enabled detection and assessment of Parkinson's disease using nocturnal breathing signals. Nat Med. 2022, 28:2207-15. 10.1038\/s41591-022-01932-x","journal-title":"Nat Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/114645-preliminary-effects-of-osteopathic-manipulative-medicine-on-reactive-oxygen-species-in-parkinsons-disease-a-randomized-controlled-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:43Z","timestamp":1707508123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/114645-preliminary-effects-of-osteopathic-manipulative-medicine-on-reactive-oxygen-species-in-parkinsons-disease-a-randomized-controlled-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":79,"URL":"https:\/\/doi.org\/10.7759\/cureus.31504","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}